Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Times Interest Earned (2018 - 2022)

Historic Times Interest Earned for Lipocine (LPCN) over the last 5 years, with Q2 2022 value amounting to -$466.11.

  • Lipocine's Times Interest Earned fell 79516.21% to -$466.11 in Q2 2022 from the same period last year, while for Mar 2023 it was -$1760.9, marking a year-over-year decrease of 875971.66%. This contributed to the annual value of -$447.24 for FY2022, which is 299050.13% down from last year.
  • Latest data reveals that Lipocine reported Times Interest Earned of -$466.11 as of Q2 2022, which was down 79516.21% from -$160.36 recorded in Q1 2022.
  • Over the past 5 years, Lipocine's Times Interest Earned peaked at $398.86 during Q4 2021, and registered a low of -$466.11 during Q2 2022.
  • Over the past 5 years, Lipocine's median Times Interest Earned value was -$34.47 (recorded in 2020), while the average stood at -$41.5.
  • As far as peak fluctuations go, Lipocine's Times Interest Earned skyrocketed by 77395.09% in 2021, and later plummeted by 79516.21% in 2022.
  • Over the past 5 years, Lipocine's Times Interest Earned (Quarter) stood at -$10.77 in 2018, then tumbled by 106.81% to -$22.26 in 2019, then tumbled by 165.82% to -$59.18 in 2020, then surged by 773.95% to $398.86 in 2021, then crashed by 216.86% to -$466.11 in 2022.
  • Its Times Interest Earned stands at -$466.11 for Q2 2022, versus -$160.36 for Q1 2022 and $398.86 for Q4 2021.